The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,101,630 in first-year total cost, median $422,042.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MCT2-C (01)]2
- Cancer Molecular Pathobiology Study Section[CAMP]1
- Cellular Signaling and Regulatory Systems Study Section[CSRS]1
- Developmental Therapeutics Study Section[DT]1
Most frequent institutions
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
- BOSTON CHILDREN'S HOSPITAL1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF COLORADO DENVER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Developing novel polytherapies for Non-Clear Cell Renal Cell Carcinoma1R01CA250378-01A1 | THOMAS, GEORGE VICTOR | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $422,042 | DT |
| 2020 | Gasdermin E and pyroptosis in cancer1R01CA240955-01A1 | LIEBERMAN, JUDY | BOSTON CHILDREN'S HOSPITAL, MA | $504,066 | CAMP |
| 2020 | Autophagy regulation of apoptosis and necroptosis within cell populations2R01CA150925-11A1 | THORBURN, ANDREW M | UNIVERSITY OF COLORADO DENVER, CO | $361,520 | CSRS |
| 2019 | Role of necroptosis in colorectal cancer therapy1R01CA236271-01A1 | ZHANG, LIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $445,723 | ZRG1 |
| 2019 | A novel mitotic regulatory axis in neuroendocrine prostate cancer1R01CA229431-01A1 | WANG, QIMING JANE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $368,279 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.